The majority of MSC applications include the therapy of immune- and inflammation-mediated disorders as well as tissue degradation, with MSCs showing significant promise for the treatment of incurable diseases.
One of the subpopulations of EVs is referred to as "exosomes." Apoptotic bodies and microvesicles/shedding particles are the other two subpopulations (both larger than 100 nm). Exosomes are created when late endosomes, or so-called multivesicular structures, sprout intraluminal vesicles (ILVs) in their luminal region (MVBs).
GET TO KNOW US
Stemcelline’s founding father and greatest pillar of strength, Dr Shouvik Pine, is a well-known Stem cell Scientist and Physician with a specialisation in research of stem-cellular products and regenerative medicine.